Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials

BACKGROUND: Mesenchymal stromal cells (MSCs) are considered to have a modest benefit on left ventricular ejection fraction (LVEF) in patients with acute myocardial infarction (AMI). However, the optimal injection timing and dose needed to induce beneficial cardiac effects are unknown. The purpose of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Res Ther
Main Authors: Wang, Zi, Wang, Lingling, Su, Xuan, Pu, Jun, Jiang, Meng, He, Ben
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5273801/
https://ncbi.nlm.nih.gov/pubmed/28129790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0450-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados